Identification of factors that exacerbate a disease is important for the development of biomarkers. In this study, we discovered ectopic overexpression of interleukin-1 family, member-6 (IL-1F6) in several murine renal diseases. IL-1F6 participates in cytokine/chemokine production in the epithelium. In PCR array analysis for inflammatory mediators, Il1f6 showed the highest expression in the kidney of the B6.MRLc1 glomerulonephritis model. IL-1F6 was localized in the epithelium from the DCTs to CCDs, which showed tubular dilations or epithelial deciduations. Ultrastructual examination of the epithelial cells revealed that IL-1F6 was localized on the cytoplasmic ribosome, vesicles, and nucleus. In and around these tubules, we found infiltrations of CD3-positive T-cells and nestin-or a-smooth-muscle actin-positive mesenchymal cells. Expression of the IL-1F6 protein and Il1f6 mRNA in the kidney was increased by the development of TILs in the B6.MRLc1 model and in lupus (BXSB, NZB/WF1, and MRL/lpr), nephrotic syndrome (ICGN), and streptozotocin-induced diabetic models. IL-1F6 was also detected in the epithelia having squamous or deciduous contours in other organs such as the skin, esophagus, thymus, or uterus. In vitro analysis using M-1 cells from the murine collecting duct revealed that Il1f6 mRNA induction was related to the upregulation of IL-6, TGF-b receptor-1, and mesenchymal markers and to the downregulation of epithelial markers and changes in the squamous cells of the epithelium. Interestingly, urine Il1f6 mRNA expression was detected earlier than renal dysfunctions in these mouse models. Ectopic overexpression of IL-1F6 in kidneys is associated with TILs and especially with cell infiltrations and changes in epithelial morphology. We propose that local overexpression of IL-1F6 is related to the development of TILs.
It is predicted that the global population of patients with end-stage renal disease (ESRD) will increase from 4.3 (1990s) to 21 .0 million (2010s). 1 Chronic kidney disease (CKD) progresses to ESRD and can lead to development of risk conditions such as diabetes and hypertension (http:// www.kidney.org/kidneydisease/ckd/index.cfm). Chronic glomerulonephritis (CGN) and diabetic nephropathy (DN) are the major primary CKDs that necessitate dialysis. 2 The most important strategy for control of CKD is development of a diagnostic method that can detect CKD at early stages. Recent studies have attempted to discover new biomarkers for renal diseases and elucidate their correlations with disease states. These studies reported that several factors that exacerbate renal disease, such as kidney injury molecule-1, monocyte chemoattractant protein-1, meprin, and osteopontin, could serve as biomarkers for injury of the proximal tubule (PT) epithelium, progression of DN, renal ischemiareperfusion injury, and focal segmental glomerulosclerosis, respectively. [3] [4] [5] [6] Typically, in order to discover new biomarkers, a comprehensive analysis of the genes that are upregulated in these diseases is essential. 7 Microarray is a very useful analytical method; however, a large number of the relevant genes might be affected by the genetic background of the patients and/or systemic diseases. Therefore, to establish new biomarkers, it is necessary to focus on factors that aggravate the disease. Kim et al 8 reported that renal expression of inflammatory cytokines such as interleukin-1 (IL-1) was elevated in the early stages of murine immune-complex kidney disease. Furthermore, Teramoto et al 9 showed that mRNA expression of chemokines and their receptors was upregulated in the glomerulus in the case of murine lupus nephritis (LN).
According to a report by Nangaku 10 , impairment of renal function correlates with tubulointerstitial lesions (TILs) rather than glomerular damage. Therefore, understanding the severity of TILs is important for prognosis. In a previous study, we developed the B6.MRLc1 congenic mouse strain, which carried telomeric regions of chromosome-1 from the MRL/MpJ lupus-prone strain, as a CGN model. [11] [12] [13] The B6.MRLc1 strain develops glomerular lesions from 6 months of age, and aged females eventually develop TILs; we therefore believe that chronic disease progression in this model more closely resembles CKD in humans than do other gene mutation mouse models with severe disease. Furthermore, since the B6.MRLc1 strain has a clear genetic background and exhibits renal histopathological features, the B6.MRLc1 model is more suitable for the identification of factors that exacerbate renal diseases.
In the present study, by using aged B6.MRLc1 mice with CGN, we performed a comprehensive PCR array analysis that targeted various inflammatory mediators in an effort to identify factors that exacerbate renal diseases. The results of in vitro and in vivo assessment of several murine disease models indicated that IL-1 family, member-6 (IL-1F6) is closely associated with development of TILs.
MATERIALS AND METHODS Animals and Sample Preparations
The investigators adhered to the Guide for the Care and Use of Animals of the School of Veterinary Medicine, Hokkaido University. The B6.MRLc1 CGN mouse model had already been generated in our previous studies.
11 -13 Female C57BL/6 mice (control); male BXSB, female NZB/W F1, and female MRL/lpr mice (LN models); and male DBA/2 mice (streptozotocin (STZ)-induced diabetes model) were purchased from an animal-breeding company (Japan SLC, Nishi-Ku, Japan). The male ICGN nephrotic syndrome (NS) mouse strain was purchased from the Laboratory Animal Resource Bank, National Institute of Biomedical Innovation (Osaka, Japan). All animals were maintained under specific pathogen-free (SPF) conditions. The animals were divided into early-and late-stage groups according to disease severity: 4 and 5 months in male BXSB mice, 4 and 7 months in female NZB/W F1 and MRL/lpr mice, 3 weeks and 3 months in male ICGN mice, and 4 and 6 months in female C57BL/6 mice. Under deep anesthesia (pentobarbital sodium; 50 mg/kg administered intraperitoneally), animals were killed by exsanguination from carotid arteries, and humoral and organ samples were collected. The organs were fixed by immersion or perfusion using 4% paraformaldehyde (PFA) for histological or electron microscopic analysis. The remaining parts were stored fresh in RNAlater solution (Ambion, Austin, TX, USA) or at À801C.
We referred to previous reports for the protocol for STZinduced diabetes. 14, 15 Briefly, diabetes was induced with intraperitoneal injections of STZ (Calbiochem, San Diego, CA, USA) dissolved in 0.05 M sodium citrate buffer (pH 4.5). Mice received two rounds of injections of 40 mg/(kg day) STZ for 5 consecutive days, first at 8 weeks of age, and then, at 12. The control animals received injections of citrate buffer. Fifteen-week-old mice were killed for analysis.
Serological Analysis and Urinalysis
In order to evaluate renal functions, serum blood urea nitrogen (BUN) and creatinine levels in all animals and urine glucose levels of diabetic mice were determined using BUN-test-Wako, Creatinine-test-Wako (Wako Pure Chemical Industries, Osaka, Japan), and Albusticks (Bayer Medical Corporation, Ebisu, Japan), respectively, according to the manufacturer's instructions. Urinary albumin was detected by the methods of combined sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and gel staining, as reported previously.
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PCR Array Analysis
To identify the factors that exacerbate the disease, PCR array analysis was performed and the relative expressions of 84 inflammatory cytokines, chemokines, and their receptors were examined. Total RNAs were purified from the stocked kidneys of 12-month-old female C57BL/6 and CGN mice using TRIzol reagent (Invitrogen, Carlsbad, CA, USA); the kidneys were stored in RNAlater solution. After purification of the total RNAs with an RNeasy Micro kit (Qiagen, Germantown, MD, USA), the RNAs were treated with Turbo DNase (Ambion) for DNA digestion and then purified again. One microgram of total RNA was synthesized to cDNAs using the RT 2 PCR Array First Strand kit (SuperArray, Frederick, MD, USA). PCR array analysis was performed using 10 ml of cDNA solution, Inflammatory Cytokines and Receptors RT 2 Profiler PCR Arrays Type A version 3 (SuperArray), and the MX 3000 thermal cycler (Stratagene, La Jolla, CA, USA).
Cell Culture
Molecular and morphological changes in the epithelium after Il1f6 induction were investigated using M-1 cells derived from murine renal collecting duct epithelium; these cells were purchased from Dainippon Sumitomo Pharma (Osaka, Japan). The cells were maintained in Ham's F-12 mediumDulbecco's modified Eagle's medium (DMEM/F12) (1:1) supplemented with 5% fetal bovine serum (FBS), penicillin and streptomycin (100 U/ml), 2 mM glutamine, and 5 mM dexamethasone at 371C in a humidified incubator with 5% CO 2 up to 80% confluence in six-well dishes (BD Falcon, Franklin Lakes, NJ, USA). After 12-h stimulation at 371C by serum or urine (10-100 ml) from C57BL/6 and MRL/lpr mice or spleen cells (8 Â 10 3 to 4 Â 10 4 cells) from C57BL/6 mice, cultured cells were collected using 0.25% trypsin/ethylenediaminetetraacetic acid (EDTA) for molecular biological analysis. For morphological analysis, parts of cells were cultured on solid collagen gel (Nitta Gelatin, Toronto, ONT, Canada), stimulated by the same conditions with palate cultures, and fixed with 4% PFA.
Reverse Transcription and Real-Time PCR To examine mRNA expressions, total RNAs from stocked organs were purified using TRIzol reagent (Invitrogen) and the SV Total RNA Isolation System for cultured cells (Promega, Madison, WI, USA). DNase-treated total RNAs were synthesized to cDNAs and PCR for amplification and quantitative real-time PCR analysis were performed as described previously. 12, 13 Quantitative data were normalized to the expression of housekeeping Actb. Details of the specific primers used for each gene are provided in Table 1 .
Immunoblotting Stored kidneys were homogenized in modified RIPA lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, 1 mM PMSF, and 10 ml protease inhibitor cocktail; Sigma, St Louis, MO, USA). Soluble protein was extracted by centrifugation at 10 000 g for 10 min at 41C. Four-fold concentrated SDS-sample buffer (200 mM Tris-HCl (pH 6.8), 40% glycerol, 8% SDS, 0.04% bromophenol blue, and 24% 2-mercaptoethanol) was added to the extracted solutions and heated at 1001C for 3 min. Electrophoresis was performed using 12.5% polyacrylamide gel (e-PAGEL; ATTO, Tokyo, Japan) and the protein was transferred to a polyvinylidene fluoride (PVDF) membrane (ATTO) by using a current density of 20 mA/mm 2 . Blocking was performed in a 1 Â Chemiblocker (Millipore, Billerica, MA, USA) at room temperature for 1 h. Goat anti-mouse IL-1F6 antibody (R&D Systems, Minneapolis, MN, USA) diluted to 1:1000 was used as the primary antibody and was incubated with the protein sample overnight at 41C. Then, the proteins were washed with TBS/0.1% Tween-20 and reacted with horseradish peroxidase (HRP)-labeled donkey anti-goat IgG diluted to 1:20 000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at room temperature for 1 h. Immunoreaction detection was performed using Immobilon Western Detection Reagent (Millipore).
Histological Analysis
Paraffin-embedded sections (2 mm) of kidneys and collagencultured cells were stained with periodic acid Schiff (PAS) or Masson's trichrome (MT). For indices of proteinuria, the total number of urinary casts per PAS-stained kidney section was determined. For indices of renal fibrosis, digital images of the kidney sections stained with MT were prepared, and the area showing blue staining per total area of interstitial regions was measured using Image J version 1.32j (National Institutes of Health, Bethesda, MD, USA).
IHC Analysis
Indirect methods were preformed as described previously. [11] [12] [13] The primary antibodies used were goat anti-mouse IL-1F6 antibodies (R&D Systems) at 1:400 dilution, rabbit antimouse CD3 antibodies (Dako, Glostrup, Denmark) at 1:200 dilution, rabbit anti-mouse nestin antibodies (Covance, Princeton, NJ, USA) at 1:4000 dilution, and rabbit anti-human a-SMA antibodies (Thermo Scientific, Waltham, MA, USA) at 1:150 dilution. For antigen retrieval, sections were autoclaved in 10 mM citrate buffer (pH 6.0) at 1051C for 15 min for IL-1F6, nestin, and a-SMA; the sections were incubated with 0.1% pepsin/0.2 M HCl at 371C for 5 min for CD3.
Whole-Mount IHC Analysis
Whole-mount immunohistochemical (IHC) analysis was performed to determine the localization of the IL-1F6 protein in the nephrons and collecting ducts. Whole kidneys from CGN mice were fixed in 4% PFA and digested by incubation with 0.1 mg/ml collagenase/phosphate-buffered saline (PBS) solution (Gibco) for 1 h at 371C; connective tissues were microdissected under a stereoscopic microscope. After incubation with 6% H 2 O 2 /methanol to eliminate internal peroxidases, the specimens were washed with 100% methanol and incubated in dimethyl sulfoxide/methanol (1:1) containing 2.5% Triton-X for 30 min. The specimens were washed with TST (10 mM Tris-HCl (pH 7.8), 150 mM NaCl, 1% Triton-X) and blocked for 6 h at room temperature with 5% skim milk/TST. For dilution of both primary and secondary antibodies, the above blocking solutions were used. Goat anti-mouse IL-1F6 antibody (R&D Systems) at 1:400 dilution was used as the primary antibody and applied to the specimens for 2 days at 41C with mild rotation. The specimens were then rinsed with TST for 8 h and reacted with 1:100 diluted HRP-labeled donkey anti-goat IgG (Santa Cruz Biotechnology) overnight at 41C with mild rotation. The specimens were again rinsed with TST for 8 h and incubated with 250 mg/ml diaminobenzidine (DAB) solution/TST for 30 min on ice; 0.003% H 2 O 2 was added for color development. The specimens were then washed with TST, post-fixed in 4% PFA for 20 min, and observed under a stereoscopic microscope.
Immunofluorescence Analysis
After antigen retrieval with 10 mM citrate buffer (pH 6.0) and serum blocking, immunofluorescence was performed as described in a previous study. [12] [13] In the first reaction, goat anti-mouse IL-1F6 antibodies (R&D Systems) at a dilution of 1:200 and tetramethylrhodamine isothiocyanate (TRITC)-conjugated rabbit anti-goat IgG antibodies (Zymed, San Francisco, CA, USA) at a dilution of 1:100 were used.
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O Ichii et al For double staining with hepatocyte nuclear factor-4a (Hnf4a) and nestin, rabbit anti-Hnf4a antibodies (Cell Signaling Technology, Beverly, MA, USA), rabbit anti-nestin antibodies (Covance) at 1:100 dilution, and fluorescein sothiocyanate (FITC)-conjugated goat anti-rabbit IgG antibodies (Zymed) at 1:100 dilution were used, and the sections were examined under a fluorescence microscope (FSX100; Olympus).
Immunoelectron Microscopy
To investigate the cellular localization of this protein, the following post-embedding method was performed: kidney specimens were fixed in a solution of 4% PFA in 0.1 M phosphate buffer (PB) overnight at 41C. The specimens were thoroughly washed in PB and then dehydrated by washing with a graded ethanol series; subsequently, the specimens were embedded in LR White resin (Ohken, Tokyo, Japan) and polymerized at 601C. Ultrathin sections were cut and mounted on nickel grids, and were subjected to the following treatments: (a) washing in PBS; (b) blocking with 1% normal donkey serum/PBS for 60 min; (c) incubation with a 1:100 dilution of goat anti-mouse IL-1F6 antibody (R&D Systems) in blocking solution for 1 h at room temperature; (d) washing in PBS; (e) incubation with a 1:200 dilution of biotinylated donkey anti-goat IgG (Santa Cruz) for 30 min; (f) washing in PBS; (g) incubation with a 1:100 dilution of gold (diameter, 10 nm)-conjugated streptavidin (British Biocell International, Cardiff, UK); (h) fixation in 1.25% glutaraldehyde/PBS for 5 min; and (i) washing in distilled water. After air-drying, the sections were stained with lead citrate.
Statistical Analysis
Results were expressed as mean (standard error (s.e.)) and statistically analyzed using non-parametric Mann-Whitney U-test (Po0.05). Correlation between two parameters was analyzed using Pearson's correlation test (Po0.001).
RESULTS
Selection of Factors that Exacerbate Renal Disease
To evaluate candidate factors for renal diseases, PCR array analysis targeting 84 inflammatory cytokines, chemokines, and their receptors was performed using kidneys from aged female C57BL/6 control and CGN model mice (Table 2 and Supplementary File 1). In the CGN mouse, genes for the chemokine (C-X-C motif) ligand (Cxcl), the chemokine (C-C motif) ligand (Ccl), and their receptors (Ccr and Cxcr) were upregulated. We found that the Il1f6 cytokine showed the highest expression level in CGN model mice (186-fold vs C57BL/6). Elevation in the expression level of the Il1f6 cytokine was remarkable as compared with that of the other IL-1 family genes such as IL-1a, IL-1b, IL-18, and IL-1F8 (Supplementary File). Proteinuria and fibrosis scores were used as indices of TILs; they were histoplanimetrically calculated and compared to the number of IL-1F6-positive tubules in CGN models. Higher scores were associated with a significantly high number of IL-1F6-positive tubules (Figure 1e and f).
IL-1F6 and TILs in CGN Kidneys
IL-1F6 mRNA and Protein Expression in CGN Kidneys
The female CGN model mice showed greater disease severity than male CGN mice. [11] [12] [13] In accord with this tendency, female CGN mice showed higher Il1f6 mRNA expression than male CGN mice and higher Il1f6 mRNA expression than both male and female C57BL/6 mice at 12 months 
IL-1F6 Protein Localization in CGN Kidneys
Whole-mount IHC analysis of CGN kidneys showed IL-1F6-reactions in the cortex (Figure 2a) . IL-1F6-positive reactions were observed in epithelia from the distal convoluted tubules (DCTs) to the cortical collecting ducts (CCDs) in single nephrons (Figure 3b-e) . Figure 3 shows the IHC localization of IL-1F6 in CGN kidneys. In DCTs, IL-1F6 was observed in the deciduous epithelia (Figure 4a) , while in CCDs, IL-1F6 showed heterogeneous reaction patterns (Figure 4b ). Dilated tubular epithelium facing urinary casts showed squamous change and strong IL-1F6-positive reactions (Figure 4c) . Additionally, mononuclear cells were observed to infiltrate some IL-1F6-positive tubules (Figure 4d ). IL-1F6-positive reactions were not merged with the Hnf4a-positive reactions, which was the marker for PTs (Figure 4e ). Immunoelectron microscopic analysis of IL-1F6 revealed the presence of gold particles in both the cytoplasm and the nucleus of the renal tubular epithelium (Figure 4e ). In the cytoplasm, the gold particles were mainly found to be located in the free ribosomes (Figure 4f ). Furthermore, vesicles containing the gold particles were localized at the apex of epithelium and in the lumen of the tubules (Figure 4g ).
IL-1F6 mRNA and Protein Expression in Several Renal Disease Models
We assessed the relative Il1f6 mRNA expression and the number of IL-1F6-positive tubules in the kidneys of LN (BXSB, NZB/WF1, MRL/lpr) and NS (ICGN) models ( Figure 5 ). In the early stages of the disease, mRNA expressions were significantly higher in BXSB mice than in C57BL/6 mice ( Figure 5a ). In the late stage of the disease, IL-1F6 mRNA expression was found to be higher in all the disease model mice than in the control C57BL/6 mice; in particular, MRL/lpr and NS models showed significant differences (Figure 5c ). Further, the number of IL-1F6-positive tubules was significantly higher in all the disease model mice than in the C57BL/6 mice in both the early and late stages of the disease (Figure 5b and d) .
In the STZ-induced diabetic model mice, blood and urine glucose increased with age to significantly higher values than those in the control mice (Figure 6a and b) . In our previous study, we had confirmed that the distal tubules and collecting ducts were dilated in STZ-induced diabetic mice; however, glomerular damage was not noted in the renal cortex. 15 In the STZ group, mice with mild histopathological changes in the kidney exhibited some IL-1F6-positive tubules (Figure 6c) . Further, the number of dilated and IL-1F6-positive tubules dramatically increased in mice with severe renal damage (Figure 6d) . A significantly higher number of IL-1F6-positive tubules and more elevated Il1f6 expression were observed in mice belonging to the STZ group than in those belonging to the control group (Figure 6e and f) .
Relationships between IL-1F6 and other TIL markers were then assessed (Figure 7 ). CD3-positive cells and nestin or actin a-2 smooth muscle aorta (a-SMA)-positive cells had infiltrated around IL-1F6-positive tubules (Figure 7b, d, f,  and g ). Notably, nestin and IL-1F6 proteins were colocalized in the same epithelium (Figure 7h ). 
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IL-1F6 mRNA and Protein Expression in Whole Organs
IL-1F6 expressions in other organs were examined to predict the functions of IL-1F6. In both C57BL/6 and CGN models, Il1f6 mRNA expression was detected mainly in the eye, thymus, trachea, esophagus, stomach, ovary, and uterus ( Figure 8a) . Expression in the skin, thymus, and uterus of the CGN mice was especially stronger than that in the C57BL/6 mice, and Il1f6 expression in the kidney was detected only in the CGN model. IL-1F6 proteins were localized in the squamous or deciduous epithelium in these organs (Figure 8b-e) .
In vitro Induction of Il1f6
In order to determine its induction factor, Il1f6 mRNA expression in an M-1 cell line derived from murine collecting duct epithelium was analyzed after stimulation with serum, urine, or spleen cells of mice. We found that Il1f6 expression was only induced by co-culture with spleen cells, was dependent on the number of spleen cells, and reached a peak when stimulated with 1.6 Â 10 4 cells (Figure 9a and b).
Molecular and Morphological Changes After In Vitro
Induction of Il1f6 
Renal Functions and Urine IL-1F6 mRNA Expression
Indices for renal functions, serum BUN, serum creatinine, and urinary albumin were measured in the C57BL/6, LN, NS, and STZ-induced diabetic models (Figure 10a-c) . From these results, the LN and NS models clearly showed deterioration of renal function in the late stage of the disease. In the early stage, the NS model had severe albuminuria, and deterioration of renal function in the LN model was mild. There was no indication of renal function deterioration in the STZinduced diabetic model. Interestingly, urine Il1f6 mRNA expression was detected in the LN and NS models as well as in the STZ-induced diabetic model from the early stage of the disease (Figure 10d ). 
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Il1f6 but not a chemokine gene, showed the highest expression level. Il1f6 is also known as a member of the IL-1 (FIL1) gene family, and its product has been identified as a member of the IL-1 cytokine family. 16 The IL -1 family is composed of  IL-1a, IL-1b, IL-1Ra, IL-18, IL-1F5, IL-1F6, IL-1F7, IL-1F8,  IL-1F9, IL-1F10, and IL-33. 16 These members play important IL-1F6 in mouse models of renal diseases O Ichii et al roles in the regulation of inflammation by mediating the expression of various cytokines, chemokines, nitric oxide synthase, and MMPs. 16 Recent studies have reported that IL-1F5, IL-1F6, IL-1F7, IL-1F8, IL-1F9, and IL-1F10 (especially IL-1F6 and IL-1F8) accelerated inflammation by increasing the production of IL-6 and IL-8 in the epithelium. 17 Relationship between IL-1F6 and Development of TILs The relationship between the IL-1 family and disease has been generally reported in autoimmune diseases. 16 IL-1b has been found to be produced by macrophages, T-cells, fibroblasts, and chondrocytes in articular cavities of rheumatic patients; it also participates in local inflammation and tissue remodeling via MMPs. 16, [18] [19] [20] [21] [22] Of the recently studied IL-1 members, IL-1F8 has been associated with the pathogenesis of rheumatism by increasing IL-6 and IL-8 expression in synovial fibroblasts and chondrocytes. 16, 23 In renal diseases, it was reported that some IL-1 members aggravated renal fibrosis. 24 A previous study suggested that IL-1a-positive interstitial cells correlated with the grade of TILs in IgA nephropathy. 25 The correlation between IL-1b in interstitial cells and decline of renal function was reported in a group of primary glomerular diseases. 26 However, PCR array analysis revealed that in CGN model mice, the mRNA expression of IL-1F6 was remarkably higher than that of the other IL-1 family proteins, including IL-1a, IL-1b, IL-18, and IL-1F8 (Supplementary File). Furthermore, overexpression of IL-1F6 was observed in the kidneys of CGN-, LN-, NS-, and STZinduced diabetic mice, specifically in renal disease rather than in autoimmune disease. Thus, our study is the first to report a correlation between IL-1F6 ectopic overexpression and various renal diseases.
IL-1F6 was localized in the epithelium from the DCTs to CCDs in renal disease models, and T-cells were infiltrated around the IL-1F6-positive tubules. In vitro analysis clarified that Il1f6 mRNA expression in epithelial cells could be induced by stimulation of the immune cells. Blumberg et al 27 reported that transgenic mice overexpressing dermal IL-1F6 showed acanthosis and increase in the number of macrophages and T-cells in these lesions; they also suggested that IL-1F6 controlled tissue injuries, promoting local inflammation. These findings strongly suggested that IL-1F6 in renal tubules was associated with local vicious cycles of tubulointerstitial inflammation.
Nestin-and a-SMA-expressing cells were infiltrated around IL-1F6-positive tubules, and their numbers correlated well with TIL development. a-SMA is a conventional marker for myofibroblasts, and nestin, which is an intermediate filament and a newly reported marker for mesenchymal cells and renal fibrosis, is associated with increase in TGF-b IL-1F6 in mouse models of renal diseases O Ichii et al expression in TILs. 28 Recently, it was reported that injured distal tubular cells increased the expressions of both TGF-b and its receptors, contributing to the pathogenesis of renal fibrosis. 29 Furthermore, in DN and unilateral ureteral obstruction (UUO) rat models, dilation of renal tubules was initiated at the distal segments and these lesions progressed to TILs. 30, 31 Our findings were partially consistent with these reports, and strong IL-1F6 expression was observed in dilated tubular epithelium in renal disease models, including the STZ-induced diabetic model. We speculate that local tubular IL-1F6 production might reflect tubular damage caused not only by inflammation but also by physical changes such as elongation of tubular lumina or increase in osmotic pressure due to changes in urinary glucose concentration. Eventually, these affected regions would lead to TILs.
IL-1F6 Participates in Luminal Epithelial Deciduation
In epithelial cells, downregulation of epithelial markers and upregulation of mesenchymal markers are known as epithelial-to-mesenchymal transitions (EMTs), and these transitions are accompanied by transformation to the fibroblastoid morphology. 32 In these processes, TGF-b and its receptors play important roles, especially in the regulation of E-cadherin. 33 In the present study, co-culture of M-1 epithelial cells with immune cells resulted in increased mRNA expression of mesenchymal markers Il1f6, Il6, and Tgfbr, and decreased 
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O Ichii et al expression of epithelial markers, thereby causing transformation to the squamous morphology. These renal EMTs subsequently contribute to the development of TILs. Iwano et al 34 reported that EMTs are caused by injury to the PT epithelium, and that cells undergoing EMT eventually migrate to the tubulointerstitial space as transformed matrix-producing cells. Although no distal tubular EMT was reported, Ivanova et al 35 induced EMT in collecting ducts by TGF stimulations in vitro. However, in the present in vivo study, IL-1F6-positive cells were not observed in the renal interstitial space and their number tended to decrease in the tubular lumina. Furthermore, in our whole-organ analysis, IL-1F6 mRNA was mainly detected in organs with turnover of epithelial cells. Further, organs with IL-1F6-positive cells were prone to epithelial deciduation. Recently, EMT has been divided into stages according to changes in its related markers. 36 From these findings, we surmised that injured DCT or CCD causes early-stage EMT leading to luminal epithelial deciduations (LEDs) and that IL-1F6 might participate in this process.
Pathological Significance of IL-1F6 in Renal Disease
We concluded that renal IL-1F6 overexpression was associated with (a) cellular infiltrations leading to TILs, (b) dilations of DCTs and CCDs, and (c) LEDs in these tubules. The pathological changes in the kidney of CGN mice were initiated by damage to glomeruli and proteinuria. 13 However, IL-1F6 expression in M-1 cells was induced by inflammatory stimulations and not by the urinary protein. Furthermore, the pathological changes in the kidneys of the STZ-induced diabetic mice were initiated because of dilations of the DCT and CCD and not because of glomerular damage; 15 further, an increased number of the IL-1F6-positive tubules were observed in this model, similar to that observed in the case of CGN and LN models. Therefore, in the LN and CGN models, inflammatory process associated with cellular infiltrations in tissues surrounding the renal corpuscles close to the DCTs and CCDs would induce IL-1F6. On the other hand, tubular IL-1F6 expression could also be induced by inflammation-independent process such as dilations of the lumen in QJ;diabetic models. The distal segment of renal tubules contain the macula densa, which is found in the juxtaglomerular apparatus; the juxtaglomerular apparatus regulates the renin-angiotensin and tubuloglomerular feedback systems, which are central to the maintenance of renal function. 37, 38 Therefore, we think that tubular damage is a critical condition that results in impairment of nephron function; moreover, the DCT, which is shorter than the PT, is more prone to tubular damage than the PT. Evaluation of tubular damage is essential for understanding renal pathology and prognosis in patients.
The present study suggested that IL-1F6 was transferred to the nucleus and/or excreted in the urine. Furthermore, IL-1F6 mRNA was detected in the urine of disease model mice. These results and those of our in vitro study suggest that IL-1F6 exhibits autocrine/paracrine function, and finally enters the nucleus to mediate cell-signaling pathways IL-1F6 in mouse models of renal diseases O Ichii et al associated with epithelial morphological changes. Interestingly, IL-6, one of the cytokines mediated by IL-1F6, is associated with renal pathogenesis such as tubular regeneration and is excreted in the urine in the case of renal disease. 39, 40 In future studies, urinary IL-1F6 protein and/or mRNA as biomarker of renal injury should be evaluated about the detection sensitivity and disease specificity.
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